Summary (max 50 words):
Analyses of the effects of periodontal therapy on pregnancy outcomes show potential improvements in gestational age for births prior to 37 weeks for live births. This briefing provides an economic assessment of the evidence and discusses additional issues.
Trade-offs between stillbirths and live births with short gestational age remain problematic.
Maternal periodontal disease has emerged as a potential modifiable risk factor for adverse pregnancy outcomes. 1, 2, 3 While the recent results from the Obstetric and Periodontal Therapy [OPT] Study addressing the relationship between non-surgical periodontal therapy during pregnancy and preterm birth found no difference in the likelihood of preterm delivery by 37 weeks, the trial found (1) evidence of reductions in stillbirths or spontaneous abortions and (2) indications of increases in gestational age for births prior to 37 weeks. 4 While fetal deaths and premature births have profound human implications, an economic evaluation of periodontal treatment for pregnant women should consider the likelihood of birth and the costs associated with birth (live or stillbirth) at each week of gestation. To this end, we provide an assessment of these issues using data from the OPT study and other sources. 6 and lower health care costs during the first five years of life.
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Economic Assessment:
The top of Figure 1 uses OPT data to show gestation for all live births from 12 weeks onward. The figure suggests longer gestation for treatment than control births from 20 to 34 weeks, with little difference from 34 weeks onward. Nine treatment and 12 control patients delivered live births prior up to 22 weeks (2.9% for the control group versus 2.2% for the treatment group.) Given a paucity of data on costs for births prior to 24 weeks and the low survival rate, we focus on data for live births with gestations of greater than 22 weeks.
The first two lines in the panel below the graph show sample sizes by gestation at two week intervals up to 37 weeks for the 384 control and 399 treatment patients whose pregnancies lasted to 22 weeks. We multiply the estimated percent of live births for each two-week interval by three cost components: (1) neonatal hospital birth admission costs; 5 (2) maternal hospital charges; 6 and (3) cumulative hospitalization costs for the first five year of a child's life after the delivery admission based on a study in the United Kingdom (UK). 7 We use the same cost estimates for the treatment and control groups despite the fact that treatment births in the OPT study had a higher rate of neonatal intensive care unit (NICU) admissions and days, possibly because the treatment group may include some averted stillbirths who were more likely to require NICU care.
The on the treating physician's specialty) were converted to US dollars; adjustment for differences in treatment intensity between the UK and US was not possible.
Based on these assumptions, periodontal therapy during pregnancy results in a reduction in birth and first five year hospital costs of $1624 per woman treated. This reduction is offset by treatment costs estimated at $924 per individual. Thus, the net savings resulting from extending gestational age at delivery through periodontal treatment is $700 per woman ( Figure 1, bottom panel) . Treating the likelihood of delivery at each two week interval as independent events yields a confidence interval that has a very high upper limit ($10,000) and includes zero, meaning that periodontal treatment may be cost-effective rather than cost-saving. The small number of births at each point on the curves and the lack of actual cost data for control versus treatment patients preclude more specific determination.
In total, the recent evidence on the effect of periodontal treatment raises more questions than it answers. Although the OPT study was originally powered to determine whether the gestational-age distribution shifted (by 5, 3, and 2 weeks for gestations of 20, 25 and 30 to 35 weeks, respectively), the published study focuses on the likelihood of delivering before 37 weeks for the two groups. The calculations in Figure 1 are only for live births, and the sample size is not sufficient to sort out the important issues of differences in the rates of stillbirths and improvements in gestational ages for live births at all points on the distribution. The rough estimate of possible savings from periodontal therapy is modest and can not be estimated precisely. While the estimated savings may be low because of the assumption of intense periodontal treatment, the savings may be overestimated if the treatment group experienced greater NICU use or screening costs are included. Finally, the OPT study provided essential dental care (e.g., treatment of abscessed teeth and caries) to both treatment and control groups up to 20 weeks of gestation as well as periodontal treatment to three control patients with generalized periodontal disease progression before delivery. These treatments could further diminish any detectable effect of periodontal care.
Further evidence on the role of periodontal therapy and pregnancy outcomes remains an important agenda item. 
$700
Note: The three net saving estimates are calculated by subtracting expected treatment costs from expected control costs.
